Journal
PARASITOLOGY TODAY
Volume 16, Issue 5, Pages 213-217Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S0169-4758(99)01623-3
Keywords
-
Categories
Ask authors/readers for more resources
Recently, a Giardia vaccine has become commercially available in the USA for prevention of clinical signs of giardiasis and reduction of cyst shedding in dogs and cats. The vaccine is based upon the current state of knowledge of Giardia antigenicity and immunology. Here, Merle Olson, Howard Ceri and Douglas Morck describe studies that led to the development of this vaccine and subsequent efficacy studies. Immunoprophylaxis and immunotherapeutic application of the vaccine are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available